Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136103540> ?p ?o ?g. }
- W3136103540 endingPage "96" @default.
- W3136103540 startingPage "89" @default.
- W3136103540 abstract "Abstract Prostate cancer is known to have a relatively good prognosis, but long-term hormone therapy can lead to castration-resistant prostate cancer (CRPC). Cabazitaxel, a second-generation taxane, has been used for the CRPC treatment, but its tolerance is an urgent problem to be solved. In this study, to elucidate the acquisition mechanism of the cabazitaxel-resistance, we established cabazitaxel-resistant prostate cancer 22Rv1 (Cab-R) cells, which exhibited ∼sevenfold higher LD50 against cabazitaxel than the parental 22Rv1 cells. Cab-R cells showed marked increases in nuclear accumulation of NF-E2 related factor 2 (Nrf2) and expression of Nrf2-inducible antioxidant enzymes compared to 22Rv1 cells, suggesting that Nrf2 signalling is homeostatically activated in Cab-R cells. The cabazitaxel sensitivity of Cab-R cells was enhanced by silencing of Nrf2, and that of 22Rv1 cells was reduced by activation of Nrf2. Halofuginone (HF) has been recently identified as a potent Nrf2 synthetic inhibitor, and its treatment of Cab-R cells not only suppressed the Nrf2 signalling by decreasing both nuclear and cytosolic Nrf2 protein levels, but also significantly augmented the cabazitaxel sensitivity. Thus, inhibition of Nrf2 signalling may be effective in overcoming the cabazitaxel resistance in prostate cancer cells." @default.
- W3136103540 created "2021-03-29" @default.
- W3136103540 creator A5007615482 @default.
- W3136103540 creator A5008751751 @default.
- W3136103540 creator A5010953950 @default.
- W3136103540 creator A5020076297 @default.
- W3136103540 creator A5023842343 @default.
- W3136103540 creator A5047873301 @default.
- W3136103540 creator A5049966177 @default.
- W3136103540 creator A5066710595 @default.
- W3136103540 creator A5090170168 @default.
- W3136103540 date "2021-03-17" @default.
- W3136103540 modified "2023-09-29" @default.
- W3136103540 title "Targeting Nrf2-antioxidant signalling reverses acquired cabazitaxel resistance in prostate cancer cells" @default.
- W3136103540 cites W1757407923 @default.
- W3136103540 cites W1920914663 @default.
- W3136103540 cites W1963569255 @default.
- W3136103540 cites W1965957522 @default.
- W3136103540 cites W1971427890 @default.
- W3136103540 cites W1995445783 @default.
- W3136103540 cites W2004361934 @default.
- W3136103540 cites W2005958584 @default.
- W3136103540 cites W2013410604 @default.
- W3136103540 cites W2014077960 @default.
- W3136103540 cites W2021270662 @default.
- W3136103540 cites W2030749349 @default.
- W3136103540 cites W2050906087 @default.
- W3136103540 cites W2141724777 @default.
- W3136103540 cites W2144471412 @default.
- W3136103540 cites W2154385453 @default.
- W3136103540 cites W2156439687 @default.
- W3136103540 cites W2174049160 @default.
- W3136103540 cites W2325225492 @default.
- W3136103540 cites W2398346487 @default.
- W3136103540 cites W2519750934 @default.
- W3136103540 cites W2540537925 @default.
- W3136103540 cites W2563700945 @default.
- W3136103540 cites W2574230442 @default.
- W3136103540 cites W2587657917 @default.
- W3136103540 cites W2605047615 @default.
- W3136103540 cites W2611475096 @default.
- W3136103540 cites W2757789380 @default.
- W3136103540 cites W2800765437 @default.
- W3136103540 cites W2800869553 @default.
- W3136103540 cites W2933115845 @default.
- W3136103540 cites W2983988464 @default.
- W3136103540 cites W2998839169 @default.
- W3136103540 cites W3007533110 @default.
- W3136103540 cites W840875033 @default.
- W3136103540 doi "https://doi.org/10.1093/jb/mvab025" @default.
- W3136103540 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33729485" @default.
- W3136103540 hasPublicationYear "2021" @default.
- W3136103540 type Work @default.
- W3136103540 sameAs 3136103540 @default.
- W3136103540 citedByCount "11" @default.
- W3136103540 countsByYear W31361035402022 @default.
- W3136103540 countsByYear W31361035402023 @default.
- W3136103540 crossrefType "journal-article" @default.
- W3136103540 hasAuthorship W3136103540A5007615482 @default.
- W3136103540 hasAuthorship W3136103540A5008751751 @default.
- W3136103540 hasAuthorship W3136103540A5010953950 @default.
- W3136103540 hasAuthorship W3136103540A5020076297 @default.
- W3136103540 hasAuthorship W3136103540A5023842343 @default.
- W3136103540 hasAuthorship W3136103540A5047873301 @default.
- W3136103540 hasAuthorship W3136103540A5049966177 @default.
- W3136103540 hasAuthorship W3136103540A5066710595 @default.
- W3136103540 hasAuthorship W3136103540A5090170168 @default.
- W3136103540 hasConcept C121608353 @default.
- W3136103540 hasConcept C126322002 @default.
- W3136103540 hasConcept C185592680 @default.
- W3136103540 hasConcept C2777511904 @default.
- W3136103540 hasConcept C2777899217 @default.
- W3136103540 hasConcept C2778971682 @default.
- W3136103540 hasConcept C2780192828 @default.
- W3136103540 hasConcept C502942594 @default.
- W3136103540 hasConcept C530470458 @default.
- W3136103540 hasConcept C71924100 @default.
- W3136103540 hasConcept C96232424 @default.
- W3136103540 hasConcept C98274493 @default.
- W3136103540 hasConceptScore W3136103540C121608353 @default.
- W3136103540 hasConceptScore W3136103540C126322002 @default.
- W3136103540 hasConceptScore W3136103540C185592680 @default.
- W3136103540 hasConceptScore W3136103540C2777511904 @default.
- W3136103540 hasConceptScore W3136103540C2777899217 @default.
- W3136103540 hasConceptScore W3136103540C2778971682 @default.
- W3136103540 hasConceptScore W3136103540C2780192828 @default.
- W3136103540 hasConceptScore W3136103540C502942594 @default.
- W3136103540 hasConceptScore W3136103540C530470458 @default.
- W3136103540 hasConceptScore W3136103540C71924100 @default.
- W3136103540 hasConceptScore W3136103540C96232424 @default.
- W3136103540 hasConceptScore W3136103540C98274493 @default.
- W3136103540 hasIssue "1" @default.
- W3136103540 hasLocation W31361035401 @default.
- W3136103540 hasOpenAccess W3136103540 @default.
- W3136103540 hasPrimaryLocation W31361035401 @default.
- W3136103540 hasRelatedWork W1439531724 @default.
- W3136103540 hasRelatedWork W2056760970 @default.
- W3136103540 hasRelatedWork W2058484579 @default.